Vasudha Pharma Chem. Ltd.

We are a leading pharmaceutical company incorporated in 1994-95 in Hyderabad, Telangana, India. With a strong focus on quality and innovation, we have become a trusted name in the global market. At Vasudha Pharma Chem Limited, we specialize in manufacturing Active Pharmaceutical Ingredients (APIs) and Pharma Intermediates for the global market. Our journey began by developing cost-effective processes for piperidone and piperidine derivatives. Today, we take pride in being the world's largest manufacturer of these derivatives. Over the years, we have diversified our product portfolio and now offer over 40 APIs spanning various therapeutic areas. To fuel our growth and stay ahead of the curve, we have made significant investments in research and development (R&D). With a dedicated R&D facility housing 113 scientists, we are at the forefront of launching new products and pioneering processes. Our commitment to innovation has been instrumental in achieving remarkable financial success. Our gross sales have grown from INR 0.0164 billion in FY 1997-98 to an impressive INR 109.6 billion (US$149.62 million) in FY 2021-2022. Notably, approximately 40% of our sales come from exports, highlighting our global presence and customer trust. Founded in 1994 by M V Rama Raju. Headquartered in Hyderabad, Telangana, India. Manufacturing Facilities: Operates five manufacturing facilities strategically located in Hyderabad, Visakhapatnam. Our extensive product range includes: Active Pharmaceutical Ingredients (APIs): We offer APIs for various therapeutic areas, including anti-infectives, cardiovascular, pain management, and gastrointestinal segments. Pharma Intermediates: We specialize in the production of pharma intermediates, particularly piperidone and piperidine derivatives, which are vital components for API manufacturing. Pharmaceutical Formulations: Our expertise extends to producing pharmaceutical formulations such as tablets, capsules, injectables, and topical creams.

HETERO HEALTHCARE LIMITED

Hetero Healthcare Ltd is a leading Innovative Pharmaceutical Company in India, headquartered at Hyderabad. We aim to improve the quality life of the people with our product line and along with a continuous Research and Development process. Our team is more committed, to finding tomorrow’s cures and treatments for some of the most serious diseases. We believe that new medicines are an integral part of the healthcare system, Hetero Healthcare helps patients better by leveraging our industry-wide experience, deep technology expertise, comprehensive portfolio of Products and vertically aligned business model for the upliftment of the human life. For More Information Visit: https://www.heterohealthcare.com/ Toll-Free Number: 1800 103 4696 Landline Number: 040-40473535

Sai Life Sciences Ltd

Sai Life Sciences is built on the bedrock of partnership. We work with innovator pharma and biotech companies to accelerate the discovery, development and manufacture of complex small molecules for a healthier tomorrow. Our Vision is to support our global innovator partners bring 25 new medicines to life by 2025. And we are well on that journey.

Ind-Swift Laboratories Ltd.

Established in 1995, Ind-Swift has fast evolved towards a business model that is focused on deep-rooted domestic presence and has leveraged on high-value mature regulated markets with considerable growth in emerging markets. With world class manufacturing sites, independent State-of-the-Art R&D Centre and Regulatory approvals, the Group has embarked upon a journey to establish itself as a reliable partner in the Global Pharmaceutical Industry. In house capabilities for Development of APIs, Finished Dosage forms, Non-Infringing Process & World Class facilities for Contract Manufacturing are our inherent strengths. Ind-Swift Laboratories Ltd. is ethically driven organization that believes in bringing positive change in the world. We have been able to persist in volatile industrial conditions by our determination to deliver products that consistently confirm global quality standards. ISLL has transformed itself into an integrated, state of the art pharmaceutical manufacturer and we are on a Journey to attain unmatched heights in Industry. We are a firm incorporated with an aim to cater to the global needs of a “healthy world” through our quality products and services provided to existing and potential customers. With hands on diverse Industrial Experience, our team serves the best pharmaceutical products, ingredients and solutions custom-tailored to every client’s specific business need.

Morepen Laboratories Limited India

Morepen is a market leader in glucometers, having installed over 12 million units to date and sold nearly 1.6 million blood glucose strips, driven by an aggressive market expansion strategy into tier-2 and tier-3 cities. As a leading manufacturer of BP monitors, the company has shown impressive growth in the Point of Care (POC) diagnostics segment. In the API business, Morepen holds a leadership position in the export of six key API products: Loratadine, Montelukast, Desloratadine, Atorvastatin, and Fexofenadine, catering to numerous international markets and exporting to over 80 countries. Approximately 68% of Morepen's API products are exported, highlighting its extensive global reach. The company has demonstrated consistent growth in both its top and bottom lines through strategic investments and market expansions. Morepen maintains a debt-free status with robust financials and a negligible interest burden, underscoring its financial stability. Founded in 1984, Morepen Laboratories Limited (www.morepen.com) has established itself as a prominent leader in the pharmaceutical industry, renowned for its high-quality products and innovative solutions. The company offers a diverse range of products, including active pharmaceutical ingredients, diagnostics, and over-the-counter items. Morepen is dedicated to enhancing global health through its advanced research and development efforts.